Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Yaohong Wang Image

      Yaohong Wang

      Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div

      About Dr. Yaohong Wang

      I am an academic gastrointestinal and liver pathologist with a background in both basic science and translational research. My clinical research focuses on integrating emerging technologies to enhance the precision of diagnostic procedures for gastrointestinal and liver diseases, including AI-based histopathologic pattern recognition, spatial transcriptomics, and single-cell analysis. In parallel, I have maintained a long-standing interest in translational research, investigating the role of actin cytoskeleton remodeling in gastrointestinal epithelial cell migration, turnover, apoptosis, and oncogenesis, as well as its impact on mucosal integrity. My ultimate career goal in pathology is to integrate my pathology training and basic science research background into clinical practice and translational research to achieve excellence in patient care.

      Read More

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      1999Capital Medical University, CN, Clinical Immunology, M.Sc
      2003Peking University Health Science Center, CN, Internal Medicine, Ph.D
      1995Inner Mongolia Medical University, CN, Clinical Medicine, M.D

      Postgraduate Training

      2020-2021GI Pathology Fellow, Mayo Clinic, Rochester, Minnesota
      2016-2020Pathology Resident, University of Tennessee Health Science Center, Memphis, Tennessee
      2003-2005Postgraduate Fellow, University of Tennessee Health Science Center, Memphis, Tennessee

      Licenses & Certifications

      2024Texas Medical Board Of Physician
      2022Diplomate of American Board of Pathology, Anatomic Pathology
      2021Tennessee Board of Medical Examiners
      2021Minnesota Board of Medical Practice

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor, Vanderbilt University, 2021 - 2024

      Instructor Pathology, University of Tennessee Health Scientific Center, 2008 - 2016

      Intramural Institutional Committee Activities

      Member, PRS Executive Council, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Member, Program Evaluation Committee (PEC) (Surgical Pathology Fellowship), The University of Texas MD Anderson Cancer Center, 2025 - Present

      Member, Clinical Competency Committee (CCC) (Surgical Pathology Fellowship), The University of Texas MD Anderson Cancer Center, 2025 - Present

      Extramural Institutional Committee Activities

      Member, GE Healthcare Standard of Truth (SoT) Committee, GE Healthcare (United States), 2026 - Present

      Consultant, Boehringer Ingelheim Better Care Now Advisory Board, Boehringer Ingelheim (United States), 2025 - Present

      Advisory, 2nd International Workshop on Medical Optical Image and Virtual Microscopy (MOVI), Vanderbilt University Medical Center, 2024 - 2025

      Member, Gastrointestinal & Liver Pathology Subcommittee, Chinese American Pathologists Association, 2020 - 2021

      Member, Leadership Professionalism Development Committee, Chinese American Pathologists Association, 2020 - 2021

      Member, Research Committee, Chinese American Pathologists Association, 2020 - 2021

      Member, Resident education Committee, Chinese American Pathologists Association, 2016 - 2021

      Honors & Awards

      2020Masoud Award, University of Tennessee Health Science
      2019University of Tennessee Department of Pathology and Lab Medicine Training Grant, University of Tennessee Health Science Center
      2019CAPA-GoPath Best Abstract Award, 108th USCAP Annual Meeting
      2018West Cancer Center Training Grant, University of Tennessee Health Science Center
      2018Stowell-Orbison Award, USCAP- United States and Canadian Academy of Pthaology

      Professional Memberships

      Rodger C. Haggitt Gastrointestinal Pathology Society

      2020 - Present

      Hans Popper Hepatopathology Society

      2020 - Present

      Chinese American Pathologists Association

      2017 - Present

      United States and Canadian Academy of Pathology

      2016 - Present

      College of American Pathologists

      2016 - Present

      American Society for Clinical Pathology

      2016 - 2021

      American Gastroenterological Association

      2006 - 2012

      Selected Presentations & Talks

      Local Presentations

      1. 2023. IBD and IBD Mimickers During Cancer Treatment Regimen. Invited. Houston, Texas, US.
      2. 2022. Pathology of the Pancreas. Invited. Nashville, TN, US.
      3. 2021. Neoplastic Liver Pathology. Invited. Nashville, TN, US.
      4. 2020. Update in Steatohepatitis. Invited. Rochester, MN, US.

      National Presentations

      1. 2026. Dissecting Image and Language Contributions in Histopathologic Diagnosis: Evaluating Open-Source, Locally Deployable Vision-Language Models MedGemma and QWEN 2.5. Poster. 115th USCAP Annual Meeting. Houston, Texas, US.
      2. 2026. SOX17 Expression in Angiosarcoma and Epithelioid Hemangioendothelioma: An Immunohistochemical Study of 48 Cases. Poster. 115th USCAP Annual Meeting. Houston, Texas, US.
      3. 2023. IBD: from basic science research to clinical practice. Invited. Madison, Wisconsin, US.
      4. 2023. Pathologic Mimics of Inflammatory Bowel Disease. Invited. Winston-Salem, North Carolina, US.

      International Presentations

      1. 2026. ECHO Pathology - Diagnostic Pearls and Pitfalls in Gastrointestinal Pathology. Invited. Indonesia Pathology ECHO. Houston, US.
      2. 2023. Liver Transplant Pathology. Invited, CN.
      3. 2023. Immune Checkpoint Inhibitor Induced Gastrointestinal and Liver Injury. Invited, CN.
      4. 2023. Use of Artificial Intelligence in IBD Translational Research. Invited, CN.
      5. 2023. Villin, Actin Cytoskeleton and beyond. Invited, CN.
      Read More
      Less

      Grant & Contract Support

      Date: 2027 - 2032
      Title:HNF4 Paralog Regulation of Epithelial Barrier Dysfunction in Crohn's Disease
      Funding Source:NIH/NIDDK
      Role:Co-I
      ID:1RO1DK151673-01
      Date: 2027 - 2032
      Title:Fascin1-Dependent Epithelial Regeneration During Mucosal Healing In Ulcerative Colitis
      Funding Source:NIH/NIDDK
      Role:Co-I
      ID:1RO1DK151674-01
      Date: 2027 - 2031
      Title:Clearance-Pathway Engineering for Precision Diagnosis and Therapy of Lupus Nephritis
      Funding Source:NIH/NIDDK
      Role:Consult
      ID:R01DK145901
      Date: 2027 - 2031
      Title:Novel patient-derived cancer models for understanding epigenetic modifications and identifying new therapeutic strategies in pancreatic neuroendocrine tumors
      Funding Source:NIH/NCI
      Role:Key
      ID:1R01CA307063-01A1
      Date: 2027 - 2031
      Title:Transporter-mediated Tubular Secretion of Nanoparticles: Fundamentals and Implications
      Funding Source:NIH/NIGMS
      Role:Consult
      ID:R01GM170762
      Date: 2027 - 2031
      Title:Mechanistic insights into tumor progression and therapeutic discovery in pancreatic neuroendocrine tumors
      Funding Source:NETRF
      Role:Key
      ID:1673852
      Date: 2027 - 2030
      Title:Exploring grade-associated therapeutic vulnerabilities and underlying mechanisms in pancreatic neuroendocrine tumors
      Funding Source:CPRIT
      Role:Key
      ID:RP270255
      Date: 2026 - 2030
      Title:Margination-mediated Delivery and Glutathione-triggered Release Enabled by Renal Clearable Gold Nanoparticles
      Funding Source:NIH/NIBIB
      Role:Consult
      ID:R01EB039021

      Selected Publications

      Peer-Reviewed Articles

      1. Wang Y, Yin F, Yao J, Tan D, Huo L, Sun H, Lu W, Khan KB, Solis Soto LM, Kostousov LV, Gan Q, Zhao S, Shakhtour R, Peng Y, Zhao J, Zhang D, Liu J, Chen H, Albarracin CT, Wu Y, Sahin AA, Wang H, Ding Q. FOG1: A Highly Sensitive and Specific Diagnostic Marker for Gastroesophageal Adenocarcinoma, 2026. e-Pub 2026. PMID: 42717622.
      2. Han J, Ding Y, Gan Q, Sweeney K, Huang X, Hameed N, Weissferdt A, Wang Y, Peng Y, Sun H. TRPS1 and GATA3 expression in BRG1/SMARCA4-deficient malignant neoplasms. Hum Pathol 177, 2026. e-Pub 2026. PMID: 42398545.
      3. Clark CJ, Waddell SN, Tessmer GE, Womack CB, Xie Y, Williams BD, Endraws MA, Huddleston CT, Pulis KD, Thammathong J, Tanas K, Jangir BA, Ma D, Bicker KL, Wang Y, Weissmiller AM, Li W, Banerjee S. Novel Triazoloquinoxaline-Based Tubulin Polymerization Inhibitor Induces Necroptosis and Significantly Inhibits Metastatic Melanoma Tumor Growth. J Med Chem 69(6):6461-6489, 2026. e-Pub 2026. PMID: 41808012.
      4. Zang, C, Guo, CC, Wang, Y, Wei, P, Li, Z. TUSCAN: Tumor segmentation and classification analysis in spatial transcriptomics. PLoS computational biology 22(3):1-18, 2026. e-Pub 2026. PMID: 41843898.
      5. Halder D, Lanford RB, Esmaeilniakooshkghazi A, Hou JK, Wang Y, Khurana S. Integrated Stress Response and Necroptosis Drive Epithelial Dysfunction in Crohn's Disease: Repurposing Cancer Drugs for Permeability Barrier Healing. Gastro Hep Adv 5(7):100950, 2026. e-Pub 2026. PMID: 42254860.
      6. Halder D, Ghazi A, Wang Y, Hou JK, Verzi M, Khurana S. Pharmacologic activation of HNF4alpha/gamma Restores Epithelial Barrier Function in Crohn's disease. bioRxiv, 2025. e-Pub 2025. PMID: 41278952.
      7. Cui C, Zheng X, Deng R, Liu Q, Yao T, Wilson KT, Coburn LA, Landman BA, Yang H, Wang Y, Huo Y. Quantitative benchmarking of anomaly detection methods in digital pathology images. Mach Learn Health 1(1):010502, 2025. e-Pub 2025. PMID: 41170405.
      8. Yu, L, Yin, M, Deng, R, Liu, Q, Yao, T, Cui, C, Guo, J, Wang, Y, Wang, Y, Zhao, S, Yang, H, Huo, Y. Glo-In-One-v2. Journal of Medical Imaging 12(6), 2025. e-Pub 2025. PMID: 40727720.
      9. Godfrey T, Acidi B, Fernandes P, Bench S, González A, Yu W, Wang Y, Cao HT, Eberlin L. Ex-Vivo Evaluation of the MasSpec Pen Technology for Hepatocellular Carcinoma Margin Assessment 71(Supplement_1):i298, 2025. e-Pub 2025.
      10. Liu Z, Zhang W, Zhao X, Li Y, Hou X, Pochampally S, Waddell S, Song S, Wang Y, Pfeffer LM, Miller DD, Yue J, Li W. Abstract 3922: A p53-deficient, PTK2/cMyc-driven ovarian cancer mouse model for preclinical drug discovery, 2025. e-Pub 2025.
      11. Yu L, Yin M, Deng R, Liu Q, Yao T, Cui C, Long Y, Wang Y, Wang Y, Zhao S, Yang H, Huo Y. GLAM: glomeruli segmentation for human pathological lesions using adapted mouse model. Medical Imaging 2025: Digital and Computational Pathology 13413(2025):240-248, 2025. e-Pub 2025.
      12. Zhu J, Yin M, Deng R, Long Y, Wang, Yu, Wang, Yaohong, Zhao S, Yang H, Huo Y. Cross-Species Data Integration for Enhanced Layer Segmentation in Kidney Pathology. Proc SPIE Int Soc Opt Eng 13413, 2025. e-Pub 2025. PMID: 41334347.
      13. Bao S, Wang Y, Rudravaram G, Zhang R, Deng R, Yu X, Gao C, Li J, Li Y, Roland JT, Zuo L, Liu Q, Lau KS, Coburn LA, Wilson KT, Landman BA, Huo Y. Quantitative Analysis of Colonic Epithelial Cell Aging in a Cell-cycle like Model: Changes in Nucleus and Cytoplasm Along the Crypt Axis. Proc SPIE Int Soc Opt Eng 13413, 2025. e-Pub 2025. PMID: 41323936.
      14. Yu L, Yin M, Deng R, Liu Q, Yao T, Cui C, Long Y, Wang, Yaohong, Wang, Yu, Zhao S, Yang H, Huo Y. GLAM: Glomeruli Segmentation for Human Pathological Lesions using Adapted Mouse Model. Proc SPIE Int Soc Opt Eng 13413, 2025. e-Pub 2025. PMID: 41323934.
      15. Waddell S, Zhao G, Liu Z, Chen H, Zhang W, Wang Y, Miller DD, Yue J, Li W. VERU-111, an orally available tubulin inhibitor, suppresses ovarian tumor growth and metastasis. Journal of Pharmacology and Experimental Therapeutics 392(1):100006, 2025. e-Pub 2025. PMID: 39893008.
      16. Deng R, Cui C, Liu Q, Yao T, Remedios LW, Bao S, Landman BA, Wheless LE, Coburn LA, Wilson KT, Wang Y, Zhao S, Fogo AB, Yang H, Tang Y, Huo Y. Segment Anything Model (SAM) for Digital Pathology: Assess Zero-shot Segmentation on Whole Slide Imaging. IS&T Int Symp Electron Imaging 37, 2025. e-Pub 2025. PMID: 40190816.
      17. Ning X, Zhong Y, Cai Q, Wang Y, Jia X, Hsieh JT, Zheng J, Yu M. Gold Nanoparticle Transport in the Injured Kidneys with Elevated Renal Function Biomarkers. Adv Mater 36(36):e2402479, 2024. e-Pub 2024. PMID: 39073056.
      18. Deng R, Cui C, Remedios LW, Bao S, Womick RM, Chiron S, Li J, Roland JT, Lau KS, Liu Q, Wilson KT, Wang Y, Coburn LA, Landman BA, Huo Y. Cross-scale multi-instance learning for pathological image diagnosis. Med Image Anal 94:103124, 2024. e-Pub 2024. PMID: 38428271.
      19. Xiong J, Liu Y, Deng R, Tyree RN, Correa H, Hiremath G, Wang Y, Huo Y. Deep Learning-Based Open Source Toolkit for Eosinophil Detection in Pediatric Eosinophilic Esophagitis. Proc SPIE Int Soc Opt Eng 12933, 2024. e-Pub 2024. PMID: 40336525.
      20. Liu Y, Deng R, Xiong J, Tyree RN, Correa H, Hiremath G, Wang Y, Huo Y. Eosinophils Instance Object Segmentation on Whole Slide Imaging Using Multi-label Circle Representation. Proc SPIE Int Soc Opt Eng 12933, 2024. e-Pub 2024. PMID: 40336526.
      21. Bao S, Lee HH, Yang Q, Remedios LW, Deng R, Cui C, Cai LY, Xu K, Yu X, Chiron S, Li Y, Patterson NH, Wang Y, Li J, Liu Q, Lau KS, Roland JT, Coburn LA, Wilson KT, Landman BA, Huo Y. Alleviating tiling effect by random walk sliding window in high-resolution histological whole slide image synthesis. Proc Mach Learn Res 227:1406-1422, 2024. e-Pub 2024. PMID: 38993526.
      22. Ricaurte Archila L, Smith L, Sihvo HK, Koponen V, Jenkins SM, O'Sullivan DM, Cardenas Fernandez MC, Wang Y, Sivasubramaniam P, Patil A, Hopson PE, Absah I, Ravi K, Mounajjed T, Dellon ES, Bredenoord AJ, Pai R, Hartley CP, Graham RP, Moreira RK. Performance of an Artificial Intelligence Model for Recognition and Quantitation of Histologic Features of Eosinophilic Esophagitis on Biopsy Samples. Mod Pathol 36(10):100285, 2023. e-Pub 2023. PMID: 37474003.
      23. Deng R, Li Y, Li P, Wang J, Remedios LW, Agzamkhodjaev S, Asad Z, Liu Q, Cui C, Wang, Yaohong, Wang, Yihan, Tang Y, Yang H, Huo Y. Democratizing Pathological Image Segmentation with Lay Annotators via Molecular-empowered Learning. Med Image Comput Comput Assist Interv 14225:497-507, 2023. e-Pub 2023. PMID: 38529367.
      24. Cui C, Wang Y, Bao S, Tang Y, Deng R, Remedios LW, Asad Z, Roland JT, Lau KS, Liu Q, Coburn LA, Wilson KT, Landman BA, Huo Y. Feasibility of Universal Anomaly Detection without Knowing the Abnormality in Medical Images. Med Image Learn Ltd Noisy Data (2023) 14307:82-92, 2023. e-Pub 2023. PMID: 38523773.
      25. Cui C, Yang H, Wang Y, Zhao S, Asad Z, Coburn LA, Wilson KT, Landman BA, Huo Y. Deep multimodal fusion of image and non-image data in disease diagnosis and prognosis: a review. Prog Biomed Eng (Bristol) 5(2), 2023. e-Pub 2023. PMID: 37360402.
      26. Cui C, Bao S, Li J, Deng R, Remedios LW, Asad Z, Chiron S, Lau KS, Wang Y, Coburn LA, Wilson KT, Roland JT, Landman BA, Liu Q, Huo Y. Influence of Cell-type Ratio on Spatially Resolved Single-cell Transcriptomes using the Tangram Algorithm: Based on Implementation on Single-Cell and MxIF Data. Proc SPIE Int Soc Opt Eng 12471, 2023. e-Pub 2023. PMID: 37324550.
      27. Deng R, Cui C, Remedios LW, Bao S, Womick RM, Chiron S, Li J, Roland JT, Lau KS, Liu Q, Wilson KT, Wang Y, Coburn LA, Landman BA, Huo Y. Cross-scale Attention Guided Multi-instance Learning for Crohn's Disease Diagnosis with Pathological Images. Multiscale Multimodal Med Imaging (2022) 13594:24-33, 2022. e-Pub 2022. PMID: 36331283.
      28. Vargas EJ, Wang Y, Chen ZE, Abusaleh R, Storm AC, Martin JA, Law RJ, Dayyeh BKA, Levy MJ, Petersen B, Chandrasekhara V. Histological assessment of new cholangioscopy-guided forceps in ERCP biliary stricture sampling: a blinded comparative study. Endosc Int Open 10(9):E1233-E1237, 2022. e-Pub 2022. PMID: 36118635.
      29. Agarwal S, Wang Y, Iyer PG, Leggett CL. Incidental Colonic Ganglioneuroma on Surveillance Colonoscopy. ACG Case Rep J 9(1):e00727, 2022. e-Pub 2022. PMID: 35036457.
      30. Guo H, Zhang W, Wang J, Zhao G, Wang Y, Zhu BM, Dong P, Watari H, Wang B, Li W, Tigyi G, Yue J. Cryptotanshinone inhibits ovarian tumor growth and metastasis by degrading c-Myc and attenuating the FAK signaling pathway. Front Cell Dev Biol 10:959518, 2022. e-Pub 2022. PMID: 36247016.
      31. Archila LR, Smith L, Sihvo HK, Westerling-Bui T, Koponen V, O'Sullivan DM, Fernandez MCC, Alexander EE, Wang Y, Sivasubramaniam P, Patil A, Hopson PE, Absah I, Ravi K, Mounajjed T, Pai R, Hagen C, Hartley C, Graham RP, Moreira RK. Development and technical validation of an artificial intelligence model for quantitative analysis of histopathologic features of eosinophilic esophagitis. J Pathol Inform 13:100144, 2022. e-Pub 2022. PMID: 36268110.
      32. Habash N, Wang Y, Morava E, Ibrahim SH. An Adolescent with Chanarin-Dorfman Syndrome Presenting with Ichthyosis and Hepatic Steatosis. JPGN Rep 2(4):e137, 2021. e-Pub 2021. PMID: 37206464.
      33. Liu X, Zhao G, Huo X, Wang Y, Tigyi G, Zhu BM, Yue J, Zhang W. Adipose-Derived Stem Cells Facilitate Ovarian Tumor Growth and Metastasis by Promoting Epithelial to Mesenchymal Transition Through Activating the TGF-beta Pathway. Front Oncol 11:756011, 2021. e-Pub 2021. PMID: 35004276.
      34. Roy S, Esmaeilniakooshkghazi A, Patnaik S, Wang Y, George SP, Ahrorov A, Hou JK, Herron AJ, Sesaki H, Khurana S. Villin-1 and Gelsolin Regulate Changes in Actin Dynamics That Affect Cell Survival Signaling Pathways and Intestinal Inflammation, 2021. e-Pub 2021. PMID: 29274870.
      35. Roy S, Esmaeilniakooshkghazi A, Patnaik S, Wang Y, George SP, Ahrorov A, Hou JK, Herron AJ, Sesaki H, Khurana S. Villin-1 and Gelsolin Regulate Changes in Actin Dynamics That Affect Cell Survival Signaling Pathways and Intestinal Inflammation. Gastroenterology 154(5):1405-1420.e2, 2018. e-Pub 2018. PMID: 29274870.
      36. Abel J, Wang Y, Clark B, MT, Pearlman E, MD. 43 Discrepant Results in Microbiology: A Tale of Two Patients 149:S19, 2018. e-Pub 2018.
      37. Wang Y, George SP, Roy S, Pham E, Esmaeilniakooshkghazi A, Khurana S. Both the anti- and pro-apoptotic functions of villin regulate cell turnover and intestinal homeostasis. Sci Rep 6:35491, 2016. e-Pub 2016. PMID: 27765954.
      38. Roy S, Singh K, Wang Y, Patnaik S, George SP, Hou JK, Khurana S. Tu1849 Defining and Targeting IRGM's Mechanism of Action in Crohn's Disease 148(4):S-919, 2015. e-Pub 2015.
      39. Lee SC, Fujiwara Y, Liu J, Yue J, Shimizu Y, Norman DD, Wang Y, Tsukahara R, Szabo E, Patil R, Banerjee S, Miller DD, Balazs L, Ghosh MC, Waters CM, Oravecz T, Tigyi GJ. Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis. Mol Cancer Res 13(1):174-85, 2015. e-Pub 2015. PMID: 25158955.
      40. Wang Y, Patnaik S, Tan L, George SP, Khurana S. A New Mouse Model of Crohn's Disease 144(5):S301, 2013. e-Pub 2013.
      41. Wang Y, George S, Srinivasan K, Patnaik S, Khurana S. Actin reorganization as the molecular basis for the regulation of apoptosis in gastrointestinal epithelial cells. Cell Death Differ 19(9):1514-24, 2012. e-Pub 2012. PMID: 22421965.
      42. Gupte R, Patil R, Liu J, Wang Y, Lee SC, Fujiwara Y, Fells J, Bolen AL, Emmons-Thompson K, Yates CR, Siddam A, Panupinthu N, Pham TC, Baker DL, Parrill AL, Mills GB, Tigyi G, Miller DD. Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity. ChemMedChem 6(5):922-35, 2011. e-Pub 2011. PMID: 21465666.
      43. Wang Y, George SP, Srinivasan K, Tan L, Kaunitz JD, Khurana S. Cell Surface ATP Synthase Regulates Apoptosis in Intestinal Epithelial Cells 136(5):A758, 2009. e-Pub 2009.
      44. Mathew S, George SP, Wang Y, Siddiqui MR, Srinivasan K, Tan L, Khurana S. Potential molecular mechanism for c-Src kinase-mediated regulation of intestinal cell migration. J Biol Chem 283(33):22709-22, 2008. e-Pub 2008. PMID: 18482983.
      45. Wang Y, Srinivasan K, Siddiqui MR, George SP, Tomar A, Khurana S. A novel role for villin in intestinal epithelial cell survival and homeostasis. J Biol Chem 283(14):9454-64, 2008. e-Pub 2008. PMID: 18198174.
      46. Khurana S, Tomar A, George SP, Wang Y, Siddiqui MR, Guo H, Tigyi G, Mathew S. Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia. Exp Cell Res 314(3):530-42, 2008. e-Pub 2008. PMID: 18054784.
      47. Wang Y, George SP, Srinivasan K, Siddiqui MR, Mathew S, Tan L, Vanmiddlesworth L, Xi Q, Jaggar JH, Khurana S. 505 Reorganization of Cytoskeleton as Basis for Apoptosis 4(134):A-70, 2008. e-Pub 2008.
      48. George SP, Wang Y, Mathew S, Srinivasan K, Khurana S. Dimerization and actin-bundling properties of villin and its role in the assembly of epithelial cell brush borders. J Biol Chem 282(36):26528-41, 2007. e-Pub 2007. PMID: 17606613.
      49. Wang Y, Tomar A, George SP, Khurana S. Obligatory role for phospholipase C-gamma(1) in villin-induced epithelial cell migration. Am J Physiol Cell Physiol 292(5):C1775-86, 2007. e-Pub 2007. PMID: 17229814.
      50. Tomar A, George S, Kansal P, Wang Y, Khurana S. Interaction of phospholipase C-gamma1 with villin regulates epithelial cell migration. J Biol Chem 281(42):31972-86, 2006. e-Pub 2006. PMID: 16921170.
      51. Khurana S, Kwiatkowski DJ, Gumucio DL, Wang Y. Increased autophagy/apoptosis in the villin-gelsolin double knock out mice 124(4):A604-5, 2005. e-Pub 2005.
      52. Wang Y, S Khurana. Villin is an epithelial cell-specific anti-apoptotic protein 124(4):A605, 2005. e-Pub 2005.
      53. Deng M, Zhao JY, Tu PF, Jiang Y, Li ZB, Wang YH. Echinacoside rescues the SHSY5Y neuronal cells from TNFalpha-induced apoptosis. Eur J Pharmacol 505(1-3):11-8, 2004. e-Pub 2004. PMID: 15556132.
      54. Tomar A, Wang Y, Kumar N, George S, Ceacareanu B, Hassid A, Chapman KE, Aryal AM, Waters CM, Khurana S. Regulation of cell motility by tyrosine phosphorylated villin. Mol Biol Cell 15(11):4807-17, 2004. e-Pub 2004. PMID: 15342783.

      Review Articles

      1. Smith C, Zheng W, Dong J, Wang Y, Lai J, Liu X, Yin F. Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy. World J Gastroenterol 28(27):3297-3313, 2022. e-Pub 2022. PMID: 36158269.

      Abstracts

      1. Yin F, Yang R, Wang Y, Zheng W, Liu X. Clinicopathological Features of Intrahepatic Cholangiocarcinoma with Enteroblastic Differentiation. USCAP 115th Annual Meeting, 2026. e-Pub 2026.
      2. Ibrahim E, Wang Y, Hegazy S, Kundert P, Li Z, Wang WB, Lazar A, Ding Q, Yu W. SOX17 Expression in Angiosarcoma and Epithelioid Hemangioendothelioma: An Immunohistochemical Study of 48 Cases. USCAP 115th Annual Meeting 106(3), 2026. e-Pub 2026.
      3. Nazem A, Li X, Yin F, Zhao S, Huo Y, Yang H, Wang Y. Dissecting Image and Language Contributions in Histopathologic Diagnosis: Evaluating Open-Source, Locally Deployable Vision-Language Models MedGemma and QWEN 2.5. USCAP 115th Annual Meeting 106(3), 2026. e-Pub 2026.
      4. Zhu J, Yin M, Deng R, Long Y, Wang Y, Wang Y, Zhao S, Yang H, Huo Y. Cross-species data integration for enhanced layer segmentation in kidney pathology. Medical Imaging 2025: Digital and Computational Pathology, 2025. e-Pub 2025.
      5. Bao S, Wang Y, Rudravaram G, Zhang R, Deng R, Yu X, Gao C, Li J, Li Y, Roland JT, Zuo L, Liu Q, Lau KS, Coburn LA, Wilson KT, Landman BA, Huo Y. Quantitative analysis of colonic epithelial cell aging in a cell-cycle-like model: changes in nucleus and cytoplasm along the crypt axis. Medical Imaging 2025: Digital and Computational Pathology 13413(2025):197-204, 2025. e-Pub 2025.
      6. Bao S, Lee HH, Yang Q, Remedios LW, Deng R, Cui C, Cai LY, Xu K, Yu X, Chiron S, Li Y, Patterson NH, Wang Y, Li J, Liu Q, Lau KS, Roland JT, Coburn LA, Wilson KT, Landman BA, Huo Y. Alleviating tiling effect by random walk sliding window in high-resolution histological whole slide image synthesis. MIDL 2023 227:1406-1422, 2024. e-Pub 2024. PMID: 38993526.
      7. Cui C, Liu H, Liu Q, Deng R, Asad Z, Wang Y, Zhao S, Yang H, Landman BA, Huo Y. Survival Prediction of Brain Cancer with Incomplete Radiology, Pathology, Genomic, and Demographic Data. Medical Image Computing and Computer-Assisted Intervention:626-635, 2022. e-Pub 2022.
      8. Wang Y, Yin J, Bainter T, Mounajjed T, Torbenson M, Yasir S, Lin F, Chen E, Zongming. Von Hippel-Lindau (VHL) Protein Immunostain Helps Classify Small Duct Type Intrahepatic Cholangiocarcinoma and Indicates a Good Prognosis. 111st USCAP Annual Meeting 102(SUPPL 1):1160-1161, 2022. e-Pub 2022.
      9. Vargas EJ, Wang Y, Chen ZM, Abusaleh R, Martin JA, Storm AC, Law R, Dayyeh BK, Petersen BT, Chandrasekhara V. Comparison of a new cholangioscopy-guided forceps versus standard forceps in patients undergoing ERCP stricture biliary sampling. Gastrointestinal Endoscopy. 2021 Digestive Disease Week 93(6):AB140-AB141, 2021. e-Pub 2021.
      10. Li Y, Wang Y, Shuyu E, Yadak N, Jain R, Clark I, Amin M, Fan M. Immunosuppressive Function of CD14-Myeloid-Derived Suppressor Cells Is Promoted by Tumor-Derived IFNB1 in Hepatocellular Carcinoma. 109th USCAP Annual Meeting 100, 2020. e-Pub 2020.
      11. Wang Y, Li Y, Shuyu E, Lanjewar S, Zhang J, Clark I, Bradley R, Khan F, Gradowski J, Robins D, McGregor D, Yue J, Amin M. Protein tyrosine kinase 2 (PTK2) overexpression in ovarian carcinoma is associated with poor prognosis and distant metastasis. 109th USCAP Annual Meeting 100(SUPPL 1):1154-1154, 2020. e-Pub 2020.
      12. Wang Y, Li Y, Shuyu E, Zhang J, King L, Khan F, Yadak N, Jain R, Clark I, Boom A, Gradowski J, Amin M. Straightening Signet Rings via Convoluted Networks. 109th USCAP Annual Meeting 100(SUPPL 1):798-799, 2020. e-Pub 2020.
      13. Li Y, Gandhi J, Cheng J, Wang Y, E, Shuyu, Abel J, Kaminsky J, Abdallah A, Saad A, Amin M, Clark I. Molecular Characteristics of Hepatocellular Carcinoma with Epigenetic Activation of the 9p21. 3 Locus. 108th USACP Annual Meeting 99, 2019. e-Pub 2019.
      14. Wang Y, Zhao G, Li Y, Shuyu E, Gandhi J, Abdallah A, Abel J, Saad A, Zhang J, Clark I, David R, Yue J, Amin M. Metal Regulatory Transcription Factor 1 (MTF1): Essential Role in Ovarian Cancer Metastasis and A Poor Clinical Prognostic Molecular Marker. 108th USCAP Annual Meeting 99, 2019. e-Pub 2019.
      15. Wang Y, Roy S, Sudeep G, Patnaik S, Esmaeilniakooshkghazi A, Ahrorov A, Khurana S. Actin Dynamics Arrest by Loss of Villin and Gelsolin Perturb Intestinal Epithelium Mitochondria Homeostasis. 107th USCAP Annual Meeting 98:308-309, 2018. e-Pub 2018.
      16. Wang Y, George SP, Khurana S. Cleaved NH2-Terminal Villin Fragment Regulates Intestinal Cell Extrusion in the Villus Tip. 106th USCAP Annual Meeting 97:463a, 2017. e-Pub 2017.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 14, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top